Webinar: Screening & Treatment Of Maternal Mood & Anxiety Disorders: Tools & Steps To Enhance Treatment Engagement
Location: Online Via PsychU.org
Description: Up to 20% of women will experience mood disorder symptoms during pregnancy or the postpartum period.1 Weighing the risks and benefits of medication use during the perinatal period can be a challenge for women who are struggling with symptoms of anxiety and depression. In this webinar, Dr. Lisa Weinstock will focus on strategies to help women and their clinicians make informed decisions around pharmacologic interventions for mood disorders during pregnancy and the postpartum period.
Pregnancy & Postpartum Mental Health Overview: Postpartum Support International (PSI). (n.d.). Retrieved August 12, 2020, from https://www.postpartum.net/learn-more/pregnancy-postpartum-mental-health/.
Lisa Weinstock, MD, is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.
Bob Pitasi, PharmD, BCPP, MBA, is a paid employee of Otsuka Pharmaceutical Development & Commercialization, Inc.
Please note: Due to high levels of interest, please access this webinar via your computer. Click here to register for the 3:00pm rebroadcast.